SK bioscience Accelerates Global Outreach by Exporting Influenza Vaccines to Southern Hemisphere Markets SK bioscience has commenced the export of its SKYCellflu influenza vaccine to Southern Hemisphere markets, enhancing global vaccine access and production stability.

SK bioscience Accelerates Global Outreach by Exporting Influenza Vaccines to Southern Hemisphere Markets #South_Korea #Seongnam #Influenza_vaccine #SK_bioscience #SKYCellflu